Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.
2.

Emotion regulation in women with premenstrual dysphoric disorder.

Petersen N, London ED, Liang L, Ghahremani DG, Gerards R, Goldman L, Rapkin AJ.

Arch Womens Ment Health. 2016 Oct;19(5):891-8. doi: 10.1007/s00737-016-0634-4. Epub 2016 May 7.

PMID:
27155663
3.

Clinical epidemiology of premenstrual disorder: informing optimized patient outcomes.

Robinson LL, Ismail KM.

Int J Womens Health. 2015 Sep 25;7:811-8. doi: 10.2147/IJWH.S48426. eCollection 2015. Review.

4.

Low-dose acetazolamide in the treatment of premenstrual dysphoric disorder: a case series.

Sani G, Kotzalidis GD, Panaccione I, Simonetti A, De Chiara L, Del Casale A, Ambrosi E, Napoletano F, Janiri D, Danese E, Girardi N, Rapinesi C, Serata D, Manfredi G, Koukopoulos AE, Angeletti G, Nicoletti F, Girardi P.

Psychiatry Investig. 2014 Jan;11(1):95-101. doi: 10.4306/pi.2014.11.1.95. Epub 2014 Jan 21.

5.

Premenstrual disorders: prevalence and associated factors in a sample of Iranian adolescents.

Delara M, Borzuei H, Montazeri A.

Iran Red Crescent Med J. 2013 Aug;15(8):695-700. doi: 10.5812/ircmj.2084. Epub 2013 Aug 5.

6.

Examination of premenstrual symptoms as a risk factor for depression in postpartum women.

Buttner MM, Mott SL, Pearlstein T, Stuart S, Zlotnick C, O'Hara MW.

Arch Womens Ment Health. 2013 Jun;16(3):219-25. doi: 10.1007/s00737-012-0323-x. Epub 2013 Jan 8.

7.

Premenstrual dysphoric disorder: evidence for a new category for DSM-5.

Epperson CN, Steiner M, Hartlage SA, Eriksson E, Schmidt PJ, Jones I, Yonkers KA.

Am J Psychiatry. 2012 May;169(5):465-75.

8.

Timing of alcohol use and the incidence of premenstrual syndrome and probable premenstrual dysphoric disorder.

Bertone-Johnson ER, Hankinson SE, Johnson SR, Manson JE.

J Womens Health (Larchmt). 2009 Dec;18(12):1945-53. doi: 10.1089/jwh.2009.1468.

9.

Update on research and treatment of premenstrual dysphoric disorder.

Cunningham J, Yonkers KA, O'Brien S, Eriksson E.

Harv Rev Psychiatry. 2009;17(2):120-37. doi: 10.1080/10673220902891836. Review.

10.

Cognitive and mood changes in men undergoing intermittent combined androgen blockade for non-metastatic prostate cancer.

Cherrier MM, Aubin S, Higano CS.

Psychooncology. 2009 Mar;18(3):237-47. doi: 10.1002/pon.1401.

11.

Premenstrual dysphoric disorder: burden of illness and treatment update.

Pearlstein T, Steiner M.

J Psychiatry Neurosci. 2008 Jul;33(4):291-301.

12.

Premenstrual syndrome.

Yonkers KA, O'Brien PM, Eriksson E.

Lancet. 2008 Apr 5;371(9619):1200-10. doi: 10.1016/S0140-6736(08)60527-9.

13.

Neurosteroids in the context of stress: implications for depressive disorders.

Girdler SS, Klatzkin R.

Pharmacol Ther. 2007 Oct;116(1):125-39. Epub 2007 May 24. Review.

14.

Persistent alterations in biological profiles in women with abuse histories: influence of premenstrual dysphoric disorder.

Girdler SS, Leserman J, Bunevicius R, Klatzkin R, Pedersen CA, Light KC.

Health Psychol. 2007 Mar;26(2):201-13.

15.

Quality of life of 'normal' controls: association with lifetime history of mental illness.

Schechter D, Endicott J, Nee J.

Psychiatry Res. 2007 Jul 30;152(1):45-54. Epub 2007 Mar 23.

16.
17.

Premenstrual Dysphoric Disorder: Recognition and Treatment.

Freeman EW, Sondheimer SJ.

Prim Care Companion J Clin Psychiatry. 2003 Feb;5(1):30-39.

Supplemental Content

Support Center